Amgen (AMGN) Sets New 52-Week Low on 'denosumab' Results
Go back to Amgen (AMGN) Sets New 52-Week Low on 'denosumab' Results| Amgen Inc (NASDAQ: AMGN) | Delayed: 432.42 -4.57 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $436.99 | 52 Week High | $176.85 | |||
| Open | $437.89 | 52 Week Low | $133.64 | |||
| Day High | $437.89 | P/E | 65.12 | |||
| Day Low | $430.72 | EPS | $6.64 | |||
| Volume | 1,739,931 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 148.35 -1.19 (0.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $149.54 | 52 Week High | $65.46 | |||
| Open | $146.72 | 52 Week Low | $47.97 | |||
| Day High | $149.01 | P/E | 100.92 | |||
| Day Low | $145.75 | EPS | $1.47 | |||
| Volume | 8,067,765 | |||||
